• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Revance Therapeutics Inc

+ Add to Watchlist

RVNC:US

30.9800 USD 0.3000 0.98%

As of 20:10:00 ET on 07/22/2014.

Company Profile for Revance Therapeutics Inc (RVNC)

Revance Therapeutics, Inc. produces biopharmaceutical products. The Company develops drug delivery and treatments for dermatology and aesthetic medicine. Revance Therapeutics serves patients and doctors throughout the United States.

Contact Information

Revance Therapeutics Inc

7555 Gateway Blvd
Newark, CA 94560
United States
Phone: 1-510-742-3400
Fax: 1-510-742-3401

Key Executives for Revance Therapeutics Inc (RVNC)

L Daniel Browne "Dan"President/CEO/Co-FounderJacob WaughChief Scientific Ofcr/Dir:Medical
Lauren P SilvernailExec VP:Corporate Dev/CFOCurtis RueggExec VP:Research & Dev
Niquette HuntSenior VP:Commercial DevDavid StykaSenior VP:Finance
Sharon HallVP:Regulatory Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil